Determinants of Subcutaneous Implantable Cardioverter-Defibrillator Efficacy

Subcutaneous implantable cardioverter-defibrillator.

or nearly 3 decades, the implantable cardioverter-defibrillator (ICD) has been available to patients who survived life-threatening rapid heart rhythms or are at risk of experiencing them. The ICD comprises a device generator coupled with a defibrillation lead. Traditional ICDs are implanted under the skin with the generator positioned beneath the collar bone. The defibrilla-tion lead is inserte...

Subcutaneous implantable cardioverter defibrillator.

Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator.

BACKGROUND The most frequent complications associated with implantable cardioverter-defibrillators (ICDs) involve the transvenous leads. A subcutaneous implantable cardioverter-defibrillator (S-ICD) has been developed as an alternative system. This study evaluated the safety and effectiveness of the S-ICD System (Cameron Health/Boston Scientific) for the treatment of life-threatening ventricula...

Implantation of the Subcutaneous Implantable Cardioverter-Defibrillator

The subcutaneous implantable cardioverter-defibrillator (S-ICD) was introduced to reduce acute transvenous leadrelated complications, such as pneumothorax, endocarditis, cardiac perforation, and lead dislodgements, as well as the complications related to chronic indwelling leads, such as lead failure, venous obstruction, and bacteremia. The standard implantation technique of the S-ICD involves ...

Subcutaneous implantable cardioverter-defibrillator (S-ICD).

Current state-of-the art implantable cardioverter-defibrillator (ICD) systems have been proven to be safe and effective in treating ventricular arrhythmias leading to cardiac death. ICDs require placement of at least one lead in, or on, the heart. Surgical placement under fluoroscopy and the ongoing presence of the transvenous leads within the patient's heart are associated with a significant p...